Ptc Therapeutics, Inc. (PTCT) Insider Ownership

Historic Insider Ownership Trends

Based on data from the past 90 days ending January 09, 2026, Ptc Therapeutics's three largest insider shareholders are Chief Executive Officer Matthew B. Klein (396.97K shares), Chief Executive Officer Stuart Walter Peltz (221.87K shares), Director Michael Schmertzler (163.27K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Matthew B. Klein Chief Executive Officer 396,967 08 Jan, 2026
Stuart Walter Peltz Chief Executive Officer 221,865 02 Feb, 2023
Michael Schmertzler 163,266 06 Jan, 2026
Neil Gregory Almstead Chief Technical Ops Officer 122,927 08 Jan, 2026
Mark Elliott Boulding Exec. Vp And Clo 117,659 08 Jan, 2026
Lee Scott Golden Evp & Chief Medical Officer 93,294 08 Jan, 2026
Pierre Gravier Chief Financial Officer 90,310 08 Jan, 2026
Eric Pauwels Chief Business Officer 87,489 08 Jan, 2026
Christine Marie Utter Svp And Chief Accounting Officer 73,727 08 Jan, 2026
Emily Luisa Hill Chief Financial Officer 38,925 29 Mar, 2023
Dawn Svoronos 29,017 10 Jun, 2022
Glenn Jr Md Phd Steele 22,500 06 Jan, 2026
Jerome B Zeldis 22,500 06 Jan, 2026
Mary L. Smith 21,813 06 Jan, 2026
Allan Steven Jacobson 21,451 06 Jan, 2026
Alethia Young 21,067 06 Jan, 2026
David P Southwell 20,850 06 Jan, 2026
Stephanie Okey 12,000 06 Jan, 2026
Emma Reeve 10,666 06 Jan, 2026
William F. Jr. Bell 10,333 16 Feb, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
07 Jan, 2026 Eric Pauwels Common Stock D 1,352 $77.48 87,489 D S
07 Jan, 2026 Neil Gregory Almstead Common Stock D 52 $77.48 6,850 I S
07 Jan, 2026 Neil Gregory Almstead Common Stock D 1,026 $77.48 116,077 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 11 $78.98 117,659 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 1,638 $77.11 118,646 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 1,503 $77.48 117,659 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock A 2,625 $38.10 120,284 D M
07 Jan, 2026 Mark Elliott Boulding Common Stock A 751 $38.10 118,410 D M
07 Jan, 2026 Mark Elliott Boulding Common Stock D 269 $77.92 117,670 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 949 $77.91 117,697 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 471 $77.10 117,939 D S
07 Jan, 2026 Mark Elliott Boulding Common Stock D 38 $78.60 117,659 D S
07 Jan, 2026 Lee Scott Golden Common Stock D 642 $77.48 93,294 D S
07 Jan, 2026 Christine Marie Utter Common Stock D 1,235 $77.45 73,727 D S
07 Jan, 2026 Matthew B. Klein Common Stock D 3,016 $77.48 396,967 D S
06 Jan, 2026 Eric Pauwels Common Stock D 1,789 $76.95 88,841 D S
06 Jan, 2026 Neil Gregory Almstead Common Stock D 54 $76.95 6,902 I S
06 Jan, 2026 Neil Gregory Almstead Common Stock D 1,279 $76.95 117,103 D S
06 Jan, 2026 Mark Elliott Boulding Common Stock D 1,739 $76.95 119,162 D S
06 Jan, 2026 Lee Scott Golden Common Stock D 1,340 $76.95 93,936 D S